首页> 美国卫生研究院文献>Frontiers in Pharmacology >Siddha Medicine in Eastern Sri Lanka Today–Continuity and Change in the Treatment of Diabetes
【2h】

Siddha Medicine in Eastern Sri Lanka Today–Continuity and Change in the Treatment of Diabetes

机译:今日斯里兰卡东部的悉达多医学–糖尿病治疗的连续性和变化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diabetes is affecting the social and economic developments in developing countries like Sri Lanka. Siddha Medicine (Tamil Medicine) is mostly practiced in the Eastern and Northern Provinces of Sri Lanka. Our recent review of Sri Lankan Siddha historical documents identified 171 plant species used to prepare anti-diabetic preparations. On the other hand, there is no study of plants currently used to treat diabetes in Sri Lankan Siddha Medicine. Hence, the aim of this study is to identify and document the plant species currently used in anti-diabetic preparations in Eastern Province, also enabling a comparative analysis with historical uses. Further, assessing the level of scientific evidence (in vitro, in vivo, and clinical studies) available for recorded species. A systematically prepared questionnaire was used to conduct an ethnobotanical survey with 27 Siddha healers residing in Eastern Province to identify the currently used anti-diabetic plants. Furthermore, Web of Science electronic database was used to assess the level of scientific evidence available excluding widespread and very well studied species. On average 325 diabetic patients were seen by 27 healers per week. Interestingly, inorganic substances, and animal parts used as ingredients in historical anti-diabetic preparations are currently not used in Eastern Province. A total of 88 plant species from 46 families were reported in this study. Syzygium cumini (L.) Skeels was the most frequently recorded species and the largest number of taxa are from Fabaceae. Remarkably, one third of reported species were not stated in Sri Lankan Siddha historical documents. The highest number of plant species (59%) have been studied up to an in vivo level followed by no scientific evidence for anti-diabetic activity found (27%), clinical evidence (10%), and in vitro (2%). This is the first ethnobotanical study of plants used to treat diabetes by Siddha healers in the Eastern Province in Sri Lanka. Moreover, awareness should be created to the diabetics about the side effects of herb-drug interactions and complications caused by taking both herbal preparations and biomedical drugs.
机译:糖尿病正在影响斯里兰卡等发展中国家的社会和经济发展。 Siddha Medicine(泰米尔医学)主要在斯里兰卡的东部和北部省份使用。我们最近对斯里兰卡悉达多历史文献的审查确定了171种用于制备抗糖尿病制剂的植物。另一方面,斯里兰卡Siddha Medicine尚未对目前用于治疗糖尿病的植物进行研究。因此,本研究的目的是鉴定和记录东部省目前在抗糖尿病制剂中使用的植物种类,并使其能够与历史用途进行比较分析。此外,评估可用于已记录物种的科学证据(体外,体内和临床研究)的水平。系统地准备的调查问卷用于对居住在东部省份的27名悉达(Siddha)治疗者进行族裔植物学调查,以确定当前使用的抗糖尿病植物。此外,Web of Science电子数据库用于评估现有科学证据的水平,但不包括广泛且研究得很好的物种。每周平均有27位治疗者治疗325位糖尿病患者。有趣的是,东部省份目前未使用无机物质和动物成分作为历史性抗糖尿病药物的成分。这项研究报告了来自46个科的88种植物。 Syzygium cumini(L.)龙骨是最常记录的物种,而分类单元数量最多的是豆科。值得注意的是,斯里兰卡悉达多的历史文献中未提及所报告物种的三分之一。在体内水平之前,已经研究了最多的植物物种(59%),随后没有发现抗糖尿病活性的科学证据(27%),临床证据(10%)和体外(2%)。这是斯里兰卡东部省的悉达(Siddha)治疗师用于治疗糖尿病的植物的第一项植物学研究。此外,应该让糖尿病患者了解草药和药物相互作用以及服用草药制剂和生物医学药物引起的并发症的副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号